Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Orange Book Blog: At the Intersection of Patent Law and FDA LawC5 "Pharma Patent Lifecycles" Conference, London, June 26-27
By Aaron Barkoff
C5 will be holding a "Pharma Patent Lifecycles" conference June 26-27 in London. According to C5, "since 2001, thousands of life sciences patent professionals have made C5's Pharma Patent Lifecycles conferences their source of information for the most up-to-date legal developments surrounding patent lifecycle management."
The agenda includes numerous presentations that may be of interest to readers:
- "Critical Update on European Case Law and Legislative Developments"
- "The Impact of Regulatory Data Protection on Lifecycle Management"
- "Recent Trends and Developments in Supplementary Protection Certificates and Paediatric Extensions"
- "Successful Evergreening Strategies to Compete with Generics and Obtain PC's"
- "Effective Use of Second Medical Use (Swiss-Type) Claims to Extend Patent Lifecycles"
- "Brand Name and Generic Litigation as a Defence or Delay Tactic? UK and US Comparative"
- "How to Optimise Your Product's Lifecycle Through Successful Global Patent Lifecycle Management"
- "Industry Case Study and Break Out Session: Insight into Pfizer's European Lipitor Litigation"
In addition, a pre-conference master class is offered on June 25: "Patent Settlements Master Class: A Step-by-Step Guide to Meeting EU Anti-Competition Law Guidelines."
For more information or to register, please visit the conference website.
Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on May 28, 2008 (boomark / email).
Great-West Lifeco Must Pay $456 Million In London Life Class Action
Great-West Lifeco Must Pay $456 Million In London Life Class Action
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Medical Records
To Stay out of Pharma's Hands
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Hormone Replacement Therapy Lawsuits See Multi-Million Dollar Settlements
HRT Lawsuits Pharma Faces Multi Million Dollar Settlements

ACI Maximizing Pharmaceutical Patent Lifecycles Conference
USPTO's Bruce Kisliuk Addresses ACI Conference
Predictions Dire for U.S. Pharmaceutical Industry
C5 Pharma/Biotech IP Due Diligence Conference
PLI Advanced Patent Licensing Conference
C5 Biotech Patenting Conference









